Identification of CDKL3 as a critical regulator in development of glioma through regulating RRM2 and the JNK signaling pathway-Reference-Cited by-同舟云学术

Identification of CDKL3 as a critical regulator in development of glioma through regulating RRM2 and the JNK signaling pathway

Author:

Cui Yong¹,Yang Zhigang²,Wang Hongxiang³,Yan Yong³,Huang Qilin³,Gong Zhenyu³,Hong Fan³,Zhang Xu³,Li Weiqing⁴,Chen Juxiang³,Xu Tao³^ORCID

Affiliation:

1. Department of Neurosurgery Third Affiliated Hospital Naval Medical University Shanghai China

2. Department of Neurosurgery Zhongshan Hospital Fudan University Shanghai China

3. Department of Neurosurgery Changzheng Hospital Naval Medical University Shanghai China

4. Department of Pathology Changzheng Hospital Naval Medical University Shanghai China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

Reference39 articles.

2. Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents;Minniti G;Anticancer Res,2009

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of CDKL: An underestimated protein kinase family;International Journal of Biological Macromolecules;2024-10